Fundz
Back to SEC Filings
10-QHIGH RiskDETERIORATING

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Filed: May 19, 2026 CIK: 0001310488
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

BioForce Nanosciences is in severe financial distress with zero revenue, massive stockholder deficit of $720k, and only $6,347 in cash. The company appears to be a non-operating entity surviving solely on related party funding while accumulating over $607k in unpaid board compensation.

Red Flags Detected (6)

Zero revenue for multiple quarters with no business operations

Total liabilities ($727k) exceed total assets ($6k) by over 100x

Massive accumulated deficit of $162.5 million

3 more red flags detected

Key Takeaways

Company has no revenue-generating operations

Financial structure is unsustainable with liabilities far exceeding assets

3 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateMay 19, 2026
Risk LevelHIGH
TrendDETERIORATING
AI Confidence95%
Red Flags6

What This Means

High Risk Filing: This company is showing signs of financial stress or significant operational challenges.

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings